| abstract |
Sulfoniel-phenyl-2H- [1,2,4] oxadiazol-5-one derivatives, and their physiologically acceptable salts and physiologically functional derivatives with agonist activity of PPARdelta or PPARdelta and PPARgamma. What is described are compounds of the formula (I). These compounds are suitable for the treatment and / or prevention of fatty acid metabolism disorders and glucose utilization disorders, as well as insulin resistance, demyelination and neurodegenerative central and peripheral nervous system. |